An effectiveness trial examining the addition of zinc to the current case management package of diarrhoea in a primary health care setting (India)

ISRCTN ISRCTN96456353
DOI https://doi.org/10.1186/ISRCTN96456353
ClinicalTrials.gov number NCT00278681
Secondary identifying numbers HNI 04008
Submission date
12/09/2005
Registration date
01/02/2006
Last edited
28/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Olivier Fontaine
Scientific

World Health Organization
20, Avenue Appia
Geneva-27
CH-1211
Switzerland

Phone +41 (0)22 791 28 94
Email fontaineo@who.int

Study information

Study designEvaluation-based, randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleEffectiveness of zinc supplementation plus oral rehydration salts compared with oral rehydration salts alone as a treatment for acute diarrhea in a primary care setting: a cluster randomized trial
Study objectivesZinc supplementation together with Oral Rehydration Therapy (ORT) will:
1. Increase Oral Rehydration Sachet (ORS) use rates
2. Reduce antimicrobial use rates
3. Increase care seeking use rates during diarrhoea
Ethics approval(s)Ethcis approval received from the World Health Organization (WHO) on the 4th April 2005.
Health condition(s) or problem(s) studiedDiarrhoea
InterventionImplementation of the zinc intervention (zinc and ORT versus ORT alone) at community and primary health care level (phase III) - one year. Formative research (phase I) and pilot intervention (phase II) have already been completed - one year.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Zinc
Primary outcome measure1. Oral Rehydration Sachet (ORS) use rates per cluster
2. Antimicrobial use rates per cluster
Secondary outcome measures1. Diarrhoea prevalence
2. Duration and severity of diarrhoeal episodes
3. Hospitalisation rates (overall, for diarrhoea, for Acute Respiratory Infections [ARI])
Overall study start date01/08/2005
Completion date31/12/2006

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants6000
Key inclusion criteriaAll children with diarrhoea living in the study area.
Key exclusion criteriaAs this study is an effectiveness study, looking at the impact of the intervention implemented in normal conditions, there is no exclusion criteria.
Date of first enrolment01/08/2005
Date of final enrolment31/12/2006

Locations

Countries of recruitment

  • India
  • Switzerland

Study participating centre

World Health Organization
Geneva-27
CH-1211
Switzerland

Sponsor information

The Department of Child and Adolescent Health and Development (CAH)/World Health Organization (WHO) (Switzerland)
Research organisation

20, Avenue Appia
Geneva-27
CH-1211
Switzerland

Phone +41 (0)22 791 28 94
Email fontaineo@who.int
Website http://www.who.int
ROR logo "ROR" https://ror.org/01f80g185

Funders

Funder type

Research organisation

The Department of Child and Adolescent Health and Development (CAH)/World Health Organization (WHO) (Switzerland)

No information available

United Nations Children's Fund (UNICEF) - India

No information available

Department of Biotechnology - Ministry of Sciences and Biotechnology (India)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/05/2008 28/01/2019 Yes No

Editorial Notes

28/01/2019: Publication reference added